Amdocs Limited
Amdocs Limited (DOX) Financial Performance & Income Statement Overview
View comprehensive annual and quarterly summaries for Amdocs Limited (DOX), featuring income statements, balance sheets, and cash flow data.
Amdocs Limited (DOX) Income Statement & Financial Overview
View the income breakdown for Amdocs Limited DOX across both annual and quarterly reports.
| Metric | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|
| Revenue | $1.13B | $1.11B | $1.26B | $1.25B |
| Cost of Revenue | $698.05M | $682.26M | $824.89M | $824.50M |
| Gross Profit | $430.15M | $427.80M | $438.99M | $425.56M |
| Gross Profit Ratio | $0.38 | $0.39 | $0.35 | $0.34 |
| R&D Expenses | $81.80M | $84.33M | $90.07M | $90.37M |
| SG&A Expenses | $134.63M | $122.09M | $138.71M | $144.03M |
| Operating Expenses | $232.42M | $228.96M | $326.32M | $234.40M |
| Total Costs & Expenses | $930.47M | $911.22M | $1.15B | $1.06B |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $8.46M | $6.41M | $0.00 | $6.87M |
| Depreciation & Amortization | $46.41M | $46.41M | $49.33M | $45.89M |
| EBITDA | $244.14M | $245.25M | $111.48M | $221.75M |
| EBITDA Ratio | $0.22 | $0.22 | $0.09 | $0.18 |
| Operating Income | $197.74M | $198.83M | $112.67M | $191.17M |
| Operating Income Ratio | $0.18 | $0.18 | $0.09 | $0.15 |
| Other Income/Expenses (Net) | -$8.46M | -$6.41M | -$9.24M | -$22.17M |
| Income Before Tax | $189.27M | $192.43M | $103.44M | $169.00M |
| Income Before Tax Ratio | $0.17 | $0.17 | $0.08 | $0.14 |
| Income Tax Expense | $25.27M | $40.57M | $16.26M | $28.00M |
| Net Income | $163.24M | $151.13M | $86.44M | $140.29M |
| Net Income Ratio | $0.14 | $0.14 | $0.07 | $0.11 |
| EPS | $1.46 | $1.34 | $0.74 | $1.22 |
| Diluted EPS | $1.45 | $1.33 | $0.73 | $1.21 |
| Weighted Avg Shares Outstanding | $111.96M | $112.75M | $114.97M | $114.97M |
| Weighted Avg Shares Outstanding (Diluted) | $112.51M | $113.44M | $115.55M | $115.55M |
Financial performance has remained strong, with revenue growing from $1.25B in Q3 2024 to $1.13B in Q2 2025. Gross profit continued to perform well, with margins at 38% in the latest quarter. Operating income reached $197.74M in Q2 2025, holding a steady 18% margin. While R&D and SG&A expenses fluctuated, EBITDA remained robust at $244.14M. Net income rose to $163.24M, keeping EPS at $1.46. With disciplined cost control and operational efficiency, the company supported consistent profitability, reflecting its ability to deliver stable shareholder value.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan